Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment- dependent survival of endothelial cells

Experimental Cell Research

Volumn 253, Issue 2, 1999, Pages 663-672

  Fujikawa, Koshi ^a   De Aos Scherpenseel, Isabel ^a   Jain, Suresh K ^a   Presman, Eleonora ^a   Varticovski, Lyuba ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1;

APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL MIGRATION; CELL SURVIVAL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0033573099     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4693     Document Type: Article

References (53)

1. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 277:1997;48-50.
2. Davis S., Yancopoulos G. D. The angiopoietins: Yin and yang in angiogenesis. Curr. Top. Microbiol. Immunol. 273:1999;173-184.
3. Partanen J., Armstrong E., Makela T. P., Korhonen J., Sandberg M., Renkonen R., Knuutila S., Huebner K., Alitalo K. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol. Cell. Biol. 12:1992;1698-1707.
4. Korhonen J., Partanen J., Armstrong E., Vaahtokari A., Elenius K., Jalkanen M., Alitalo K. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood. 80:1992;2548-2555.
5. Sato T. N., Qin Y., Kozak C. A., Audus K. L. tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. USA. 90:1993;9355-9358.
6. Dumont D. J., Gradwohl G. J., Fong G.-H., Auerbach R., Breitman M. L. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene. 8:1993;1293-1301.
7. Sato T. N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M., Gridley T., Wolburg H., Risau W., Qin Y. Distinct roles of the receptor tyrosine kinases tie 1 and tie 2 in blood vessel formation. Nature. 376:1995;70-74.
8. Dumont D. J., Gradwohl G., Fong G.-H., Puri M. C., Gertsenstein M., Auerbach A., Breitman M. L. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1994;1897-1909.
9. Puri M. C., Rossant J., Alitalo K., Bernstein A., Partanen J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14:1995;5884-5891.
10. Davis S., Aldrich T. H., Jones P. F., Acheson A., Compon D. L., Jain V., Ryan T. E., Bruno J., Radziejewski C., Maisonpierre P. C., Yancopoulos G. D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1996;1161-1169.
11. Maisonpierre P. C., Suri C., Jones P. F., Bartunkova S., Wiegand S. J., Radziejewski C., Compton D., McClain J., Aldrich T. H., Papadopoulos N., Daly T. J., Davis S., Sato T. N., Yancopoulos G. D. Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science. 277:1997;55-60.
12. Suri C., Jones P. F., Patan S., Bartunkova S., Maisonpierre P. C., Davis S., Sato T. N., Yancopoulos G. D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
13. Toker A., Cantley L. C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 387:1997;673-676.
14. Franke T. F., Cantley L. C. A bad kinase makes good. Nature. 390:1997;116-117.
15. Huang L., Turk C. H., Rao P., Peters K. G. GRB2 and SH-PTP2: Potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene. 11:1995;2097-2103.
16. Kontos C. D., Stauffer T. P., Yang W.-P., York J. D., Huang L., Blanar M. A., Meyer T., Peters K. G. Tyrosine 1101 of tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol. 18:1998;4131-4140.
17. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52:1973;2745-2756.
18. Namiki A., Brogi E., Kearney M., Kim E. A., Wu T., Couffinhal T., Varticovski L., Isner J. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 270:1995;31189-31195.
19. Edgell C.-J. S., McDonald C. C., Graham J. B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA. 80:1983;3734-3737.
20. Burton R. I. A study of conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62:1956;315-323.
21. Witzenbichler B., Maisonpierre P. C., Jones P., Yancopoulos G. D., Isner J. M. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase tie2. J. Biol. Chem. 273:1998;18514-18521.
22. Susa M., Keeler M. L., Varticovski L. Platetet-derived growth factor activates membrane-associated phosphatidyinositol 3-kinase and mediates its translocation from the cytosol. J. Biol. Chem. 267:1992;22951-22956.
23. Fujikawa K., Kearney M., Krasinski K., Varticovski L. Tie 1 and 2 expression following balloon injury of rat carotid artery. J. Vasc. Res. 36:1999;272-281.
24. Gerber H.-P., McMurtrey A., Kowalski J., Yan M., Keyt B. A., Dixit V., Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival trough the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. J. Biol. Chem. 273:1998;30336-30343.
25. Araki S., Simada Y., Kaji K., Hayashi H. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem. Biophys. Res. Commun. 172:1990;1081-1085.
26. Tepper C. G., Jayadev S., Liu B., Bielawska A., Wolf R., Yonehara S., Hunna Y. S., Seldin M. F. Role of ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA. 92:1995;8443-8447.
27. Fujio Y., Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. 274:1999;16349-16354.
28. Fadoc V. A., Voelker D. R., Campbell P. A., Cohen J. J., Bratton D. L., Henson P. M. Expression of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:1992;2207-2216.
29. Downward J. Lipid-regulated kinases: Some common themes at last. Science. 279:1998;673-674.
30. Vlahos C. J., Matter W. F., Hui K. Y., Brown R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241-5248.
31. Alessi D. R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B. A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:1996;6541-6551.
32. Verheij M., Bose R., Lin X., Yao B., Jarvis W., Grant S., Birrer M., Szabo E., Zon L., Kyriakis J., Haimovitz F. A., Fuks Z., Kolesnick R. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 380:1996;75-79.
33. Zhou H., Summers S. A., Birnbaum M. J., Randall N. Inhibition of the Akt kinase by cell-permeable ceramide its implications for ceramide-induced apoptosis. J. Biol. Chem. 273:1998;16568-16575.
34. King W. G., Mattaliano M. D., Chan T. O., Tsichlis P. N., Brugge J. S. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 17:1997;4406-4418.
35. Grammer T. C., Blenis J. Evidence of MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene. 14:1997;1635-16442.
36. Thakker G. D., Hajjar D. P., Muller W. A., Rosengard T. K. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J. Biol. Chem. 274:1999;10002-10007.
37. 3. J. Biol. Chem. 269:1994;32358-32367.
38. Kulik G., Klippel A., Weber M. J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17:1997;1595-1606.
39. Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G. F., Holmes A. B., Gaffney P. R. J., Reese C. B., McCormick F., Tempst P., Coadwell J., Hawkins P. T. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science. 1998;710-714.
40. Cardone M. H., Roy N., Stennicke H. R., Salvesen G. S., Franke T. F., Stanbridge E., Frisch S., Reed J. C. Regulation of cell death protease-9 by phosphorylation. Science. 282:1998;1318-1321.
41. Brunet A., Bonni A., Zigmond M., Lin M. Z., Juo P., Hu L. S., Anderson M. J., Arden K. C., Blenish J., Greenberg M. E. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 96:1999;857-868.
42. Peli J., Schroter M., Rudaz C., Hahne M., Meyer C., Reichmann E., Tschopp J. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J. 18:1999;1824-1831.
43. Wong A. L., Haroon Z. A., Werner S., Dewhirst M. W., Greenberg C. S., Peters K. G. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ. Res. 81:1997;567-574.
44. Koblizek T. I., Runting A. S., Stacker S. A., Wilks A. F., Risau W., Deutsch U. Tie2 receptor expression and phosphorylation in cultured cells and mouse tissues. Eur. J. Biochem. 244:1997;774-779.
45. Yabkowitz R., Meyer S., Yanagihara D., Brankov D., Stley T., Elliott G., Hu S., Ratzkin B. Regulation of Tie receptor expression on human endothelial cells by protein kinase C-mediated release of soluble Tie. Blood. 90:1997;706-715.
46. Okada T., Sakuma L., Fukui Y., Hazeki O., Ui M. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:1994;3563-3567.
47. Hartwig J. H., Kung S., Kovacsovics T., Janmey P. A., Cantley L. C., Stossell T. P., Toker A. D3 phosphoinositides and outside-in integrin signaling by glycoprotein IIb-IIIa mediate platelet actin assembly and filopodial extension induced by phorbol 12-myristate 13-acetate. J. Biol. Chem. 271:1996;32986-32993.
48. Derman M. A. T., Hartwig J., Spokes K., Falk J., Chen C., Cantley L., Cantley L. The lipid products of phosphoinositide 3-kinase increase cell motility through protein kinase C. J. Biol. Chem. 272:1997;6465-6470.
49. Wennstrom S., Siegbahn A., Yokote K., Arvidsson A. K., Heldin C. H., Mori S., Claesson-Welsh L. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3′ kinase. Oncogene. 9:1994;651-660.
50. Kundra V., Escobedo J. A., Kazlauskas A., Kim H. K., Rhee S. G., Williams L. T., Zetter B. R. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature. 367:1994;474-476.
51. Hooshmand-Rad R., Claesson-Welsh L., Wennstrom S., Yokote K., Siegbahn A., Heldin C.-H. Involvement of phosphatidylinositide 3′-kinase and Rac in platelet-derived growth factor-induced actin reorganization and chemotaxis. Exp. Cell Res. 234:1997;434-441.
52. Sander E. E., S. v.D., ten Klooser J. P., Reid T., van der Kammen R. A., Michiels F., Collard J. G. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J. Cell. Biol. 143:1998;1385-1398.
53. Fruman D., Snapper S. B., Yballe C. M., Davidson L., Yu J. Y., Alt F. W., Cantley L. C. Impaired B cell development and proliferation in abscence of phosphoinositide 3-kinase p85α Science. 283:1999;393-307.